179 related articles for article (PubMed ID: 30272048)
1. Harnessing the Digital Exhaust: Incorporating wellness into the pharma model.
Wright JM; Jones GB
Digit Biomark; 2018; 2(1):31-46. PubMed ID: 30272048
[TBL] [Abstract][Full Text] [Related]
2. Can composite digital monitoring biomarkers come of age? A framework for utilization.
Kovalchick C; Sirkar R; Regele OB; Kourtis LC; Schiller M; Wolpert H; Alden RG; Jones GB; Wright JM
J Clin Transl Sci; 2017 Dec; 1(6):373-380. PubMed ID: 29707260
[TBL] [Abstract][Full Text] [Related]
3. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
4. Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
Hird N; Ghosh S; Kitano H
Drug Discov Today; 2016 Jun; 21(6):900-11. PubMed ID: 26821131
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. A systems approach towards remote health-monitoring in older adults: Introducing a zero-interaction digital exhaust.
Schütz N; Knobel SEJ; Botros A; Single M; Pais B; Santschi V; Gatica-Perez D; Buluschek P; Urwyler P; Gerber SM; Müri RM; Mosimann UP; Saner H; Nef T
NPJ Digit Med; 2022 Aug; 5(1):116. PubMed ID: 35974156
[TBL] [Abstract][Full Text] [Related]
7. Digital technology and clinical decision making in depression treatment: Current findings and future opportunities.
Hallgren KA; Bauer AM; Atkins DC
Depress Anxiety; 2017 Jun; 34(6):494-501. PubMed ID: 28453916
[TBL] [Abstract][Full Text] [Related]
8. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
9. Digital Biomarkers in Multiple Sclerosis.
Dillenseger A; Weidemann ML; Trentzsch K; Inojosa H; Haase R; Schriefer D; Voigt I; Scholz M; Akgün K; Ziemssen T
Brain Sci; 2021 Nov; 11(11):. PubMed ID: 34827518
[TBL] [Abstract][Full Text] [Related]
10. Circular Business Model for Digital Health Solutions: Protocol for a Scoping Review.
Rønn C; Wieland A; Lehrer C; Márton A; LaRoche J; Specker A; Leroy P; Fürstenau D
JMIR Res Protoc; 2023 Nov; 12():e47874. PubMed ID: 37999949
[TBL] [Abstract][Full Text] [Related]
11. Advancing Rheumatology Care Through Machine Learning.
Hügle T
Pharmaceut Med; 2024 Mar; 38(2):87-96. PubMed ID: 38421585
[TBL] [Abstract][Full Text] [Related]
12. Pharma 4.0: analysis on core competence and digital levelling implementation in pharmaceutical industry in Indonesia.
Nurlaela Arief N; Gustomo A; Rahman Roestan M; Putri ANA; Islamiaty M
Heliyon; 2022 Aug; 8(8):e10347. PubMed ID: 36082329
[TBL] [Abstract][Full Text] [Related]
13. Engaging Through Awareness: Purpose-Driven Framework Development to Evaluate and Develop Future Business Strategies With Exponential Technologies Toward Healthcare Democratization.
Barbazzeni B; Haider S; Friebe M
Front Public Health; 2022; 10():851380. PubMed ID: 35692334
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance and the digital world in Italy: presentation of the results of a national survey.
Stagi L; Bocchi I; Bianco S; Sirizzotti G; Bernardini D; Calderazzo V; Pirisino G; Grisoni I; Romano S
Ther Adv Drug Saf; 2021; 12():2042098620985991. PubMed ID: 33623659
[TBL] [Abstract][Full Text] [Related]
15. Translational bioinformatics in the era of real-time biomedical, health care and wellness data streams.
Shameer K; Badgeley MA; Miotto R; Glicksberg BS; Morgan JW; Dudley JT
Brief Bioinform; 2017 Jan; 18(1):105-124. PubMed ID: 26876889
[TBL] [Abstract][Full Text] [Related]
16. Impact of Blockchain-Digital Twin Technology on Precision Health, Pharmaceutical Industry, and Life Sciences: Conference Proceedings, Conv2X 2023.
Vasiliu-Feltes I; Mylrea M; Zhang CY; Wood TC; Thornley B
Blockchain Healthc Today; 2023; 6():. PubMed ID: 38187956
[TBL] [Abstract][Full Text] [Related]
17. An integrated data management and informatics framework for continuous drug product manufacturing processes: A case study on two pilot plants.
Chen Y; Sampat C; Huang YS; Ganesh S; Singh R; Ramachandran R; Reklaitis GV; Ierapetritou M
Int J Pharm; 2023 Jul; 642():123086. PubMed ID: 37257793
[TBL] [Abstract][Full Text] [Related]
18. Preparing a business justification for going electronic.
Ortiz AO; Luyckx MP
Radiol Manage; 2002; 24(1):14-21. PubMed ID: 11857990
[TBL] [Abstract][Full Text] [Related]
19. Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0.
Barenji RV; Akdag Y; Yet B; Oner L
Int J Pharm; 2019 Aug; 567():118445. PubMed ID: 31226474
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
